Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice

Phytotherapy Research

Volumn 28, Issue 3, 2014, Pages 363-371

  Shih, Chun Ching ^a   Shlau, Min Tzong ^a   Lin, Cheng Hsiu ^b   Wu, Jin Bin ^c  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b FENG YUAN HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

11beta hydroxysteroid dehydroxygenase; Momordica charantia; phosphoenopyruvate carboxykinase

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MESSENGER RNA; MOMORDICA CHARANTIA EXTRACT; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DRUG DOSE COMPARISON; DYSLIPIDEMIA; ENZYME REGULATION; FATTY ACID SYNTHESIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

CUCUMIS; CUCURBITACEAE; MOMORDICA CHARANTIA; MUS;

11BETA HYDROXYSTEROID DEHYDROXYGENASE; MOMORDICA CHARANTIA; PHOSPHOENOPYRUVATE CARBOXYKINASE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DYSLIPIDEMIAS; FATTY ACID SYNTHASES; FATTY ACIDS; FRUIT; GLUCOSE; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MOMORDICA CHARANTIA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PHOSPHORYLATION; PLANT EXTRACTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 84895781801     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5003     Document Type: Article

References (26)

1. Ahmed I, Lakhani MS, Gillett M, John A, Raza H,. 2001. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 51: 155-161.
2. Alberti L, Girola A, Gilardini L, et al,. 2007. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta hydroxysteroid dehydrogenase 1 in obese subjects. Int J Obes (Lond) 31: 1826-1831.
3. Alberts P, Nilsson C, Selen G, et al,. 2003. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144: 4755-4762.
4. Chen Q, Chan LLY, Li ETS,. 2003. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr 133: 1088-1093.
5. Foretz M, Taleux N, Guigas B, et al,. 2006. Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Med SCI (Paris) 22: 381-388.
6. Ho HA, Lin WC, Kitanaka S, Chang CT, Wu JB,. 2008. Analysis of bioactive triterpenes in Eriobotrya japonica Lindl. by high-performance liquid chromatography. J Food Drug Anal 16: 41-45.
7. Koeilevtsev Y, Holmes MC, Burchell A, et al,. 1997. 11β- hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94: 14924-14929.
8. Laemmli UK,. 1970. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
9. Matsuda H, Li Y, Murajami T, Matsumura N, Yamahara J, Yoshikawa M,. 1998. Antidiabetic principles of natural medicines, Part III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem Pharm Bull (Tokyo) 46: 1399-1403.
10. Patel DD, Knight BL, Wiggins D, Humphreys SM, Gibbons GF,. 2001. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice. J Lipid Res 42: 328-337.
11. Petro AE, Cotter J, Cooper DA, Peters JC, Surwit SJ, Surwit RS,. 2004. Fat, carbohydrate and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 53: 454-457.
12. Raman A, Lau C,. 1996. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 2: 349-362.
13. Reaven GM, Laws A,. 1994. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 37: 948-952.
14. Senanayake GVK, Maruyama M, Shibuya K, et al,. 2004. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J Ethnopharmacol 91: 257-262.
15. Shen QW, Jones CS, Kalchayanand N, Zhu MJ, Du M,. 2005. Effect of dietary alpha-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice. J Anim Sci 83: 2611-2617.
16. Shibib BA, Khan LA, Rahman R,. 1993. Activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1, 6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 292: 267-270.
17. Shih CC, Lin CH, Lin WL,. 2008. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res Clin Pract 81: 134-143.
18. Shih CC, Lin CH, Lin WL, Wu JB,. 2009. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J Ethnopharmacol 123 (1): 82-90.
19. Shimano H, Yahagi N, Amemiya-Kudo M, et al,. 1999. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274: 35832-35839.
20. Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N,. 2008. Bitter goud (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-tyrosine phosphorylation in high-fat-fed rats. Br J Nutr 99: 806-812.
21. Staeles B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC,. 1988. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093.
22. Stein SC, Woods A, Jones NA, Davison MD, Carling D,. 2000. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443.
23. Sun Y, Liu S, Fergusort S, et al,. 2002. Phosphoenolpyruvate carboxykinase overpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277: 23301-23307.
24. Tan M-J, Ye J-M, Turner N, et al,. 2008. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15: 263-273.
25. Viollet B, Lantier L, Devin-Leclerc J, et al,. 2009. Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci 14: 3380-3400.
26. Wakil S,. 1989. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28: 4523-4530.